Financial Contrast: Syneos Health (SYNH) vs. ALGAE TEC LTD/S (ALGXY)

Syneos Health (NASDAQ:SYNH) and ALGAE TEC LTD/S (OTCMKTS:ALGXY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for Syneos Health and ALGAE TEC LTD/S, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Syneos Health 0 2 9 0 2.82

Syneos Health currently has a consensus price target of $54.56, suggesting a potential upside of 12.05%. Given Syneos Health’s higher possible upside, equities analysts clearly believe Syneos Health is more favorable than ALGAE TEC LTD/S.

Volatility and Risk

Syneos Health has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500. Comparatively, ALGAE TEC LTD/S has a beta of 92.6, indicating that its share price is 9,160% more volatile than the S&P 500.

Earnings & Valuation

This table compares Syneos Health and ALGAE TEC LTD/S’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Syneos Health $2.67 billion 1.88 -$138.46 million $1.94 25.10
ALGAE TEC LTD/S $2.05 million 1.03 -$6.08 million N/A N/A

ALGAE TEC LTD/S has lower revenue, but higher earnings than Syneos Health.


This table compares Syneos Health and ALGAE TEC LTD/S’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Syneos Health -0.84% 8.67% 3.47%

Institutional and Insider Ownership

0.1% of ALGAE TEC LTD/S shares are owned by institutional investors. 0.6% of Syneos Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.


Syneos Health beats ALGAE TEC LTD/S on 7 of the 11 factors compared between the two stocks.

About Syneos Health

Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as unbundled service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a strategic collaboration with Elligo Health Research. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Raleigh, North Carolina.


Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.

Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with's FREE daily email newsletter.

Leave a Reply